When the Tri-Institutional Therapeutics Discovery Institute launched just over four years ago, nothing like it existed in academia. The nonprofit academic corporation – a joint venture between Memorial Sloan Kettering Cancer Center, The Rockefeller University and Weill Cornell Medicine, with Takeda Pharmaceutical Company Ltd. as their partner – was tasked with expediting the development of innovative new drugs and, more recently, antibodies, based on early discoveries at the three institutions. Take a closer look.

Children from low-income neighborhoods had a higher mortality rate and higher hospital costs after heart surgery compared with those from higher-income neighborhoods, found a national study of more than 86,000 kids with congenital heart disease. The magnitude of the neighborhood effect, which persisted even after accounting for race, type of insurance, and hospital, was similar for children of all disease severities. Take a closer look.

Two new precision medicine tests that look beyond cancer genes to identify novel therapeutic targets have just received New York State Department of Health approval and are now available to both oncologists and cancer researchers for use at the front lines of patient care. Take a closer look.

A new cellular messenger discovered by Weill Cornell Medicine scientists may help reveal how cancer cells co-opt the body’s intercellular delivery service to spread to new locations in the body. Take a closer look.

As an expert in his field, Patric K. Stanton, Ph.D., professor of cell biology and anatomy and of neurology, and a team at New York Medical College were called upon to join an elite contingent of researchers studying the origins of Chronic Traumatic Encephalopathy (CTE).  Take a closer look.

A TouroCOM Harlem student presented a groundbreaking new approach to treating strokes at this year’s International Stroke Conference. Take a closer look.

Mount Sinai researchers have shown, for the first time, the complex web of links between physical and behavioral characteristics, like age, body mass index (BMI), and substance use, and specific patterns of brain structure and function in patients with psychosis. The study is important because many of these characteristics can be targeted clinically to improve brain health in these patients. Take a closer look.

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, causes lethal respiratory paralysis within several years of diagnosis. There are no effective treatments to slow or halt this devastating disease. Take a closer look.

People aged 85 and older whose total cholesterol had increased from their levels at midlife had a reduced risk for marked cognitive decline, compared with those a decade younger whose cholesterol was similarly elevated, Mount Sinai researchers report in a new study. Take a closer look.

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell professor of medicine, Jesse Roth, MD, FACP, and fellow investigators at the Feinstein Institute for Medical Research recently discovered that the E. coli bacteria found in our intestines are communicating with cells throughout our bodies to reduce inflammation. Take a closer look. 

Analytic software developed by orthopedic trauma surgeons at NYU Langone Health accurately identifies which middle-aged and elderly patients face a greater mortality risk following surgery for an orthopedic fracture, according to a new study. Take a closer look.

Researchers at Upstate Medical University are part of $1.8 million study involving nine institutions that will investigate the recent increase in severe lung disease among coal mine workers with a close examination of the link between mine dust exposures and severe lung disease in miners. Take a closer look.

Feinstein Institute for Medical Research professors Betty Diamond, MD, and Peter K. Gregersen, MD,release data from their National Institutes of Health (NIH) research which reveals our cells’ roles in rheumatoid arthritis and lupus. Take a closer look.

In a unique forum loosely based on the hit television show, Shark Tank, executives from three Israeli biotech companies pitched their medical products to an exclusive group of entrepreneurs interested in helping the companies develop and market their products in the U.S. Take a closer look.